Marrone Bio Innovations Stock

Marrone Bio Innovations ROCE

Delisted

The Return on Capital Employed (ROCE) of Marrone Bio Innovations (MBII) as of Jul 26, 2026 is -50.38 %. In the previous year, Return on Capital Employed (ROCE) was 5.52 % — a change of -1,011.94% (lower).

ROCE

-50.38 %

YoY

-1,011.94%

Last updated:

In 2026, Marrone Bio Innovations's return on capital employed (ROCE) was -50.38 %, a -1,011.94% increase from the 5.52 % ROCE in the previous year.

Access this data via the Eulerpool API

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Marrone Bio Innovations's Return on Capital Employed (ROCE)

Marrone Bio Innovations's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Marrone Bio Innovations's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Marrone Bio Innovations's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Marrone Bio Innovations’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Marrone Bio Innovations stock

Return on Capital Employed (ROCE) of Marrone Bio Innovations is -50.38 % in 2026.

Access this data via the Eulerpool API

Profitability — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations